News
Approximately 15 million USD; Oryzon to validate epigenetic agents by applying a personalized medicine approach for rare and orphan diseases; Oryzon will explore Aggression in spe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback